ScientiaCME Free CME Courses

  • FREE

    CME: Advanced Prostate Cancer (aPC): Therapeutic Updates, Best Practices, and Emerging Treatments

    Prostate cancer is the most common form of malignancy among men in the United States.There are over 164,600 new cases and over 29,000 deaths from PC in the U.S. annually. Probable risk factors include age 65 and older, African American ancestry, family history, and mutations in the BRCA1, -2, MSH2, and HOXB13 genes, with possible risk factors including occupational exposure to cadmium, dietary factors, and higher concentrations of serum testosterone. About 95% of cases are adenocarcinoma, with neuroendocrine tumors, sarcomas, and transitional cell carcinomas comprising the balance of tumor types. Symptoms of advanced prostate cancer (aPC) include back pain, cord compression, lower extremity edema, pathologic fractures, anemia, and weight loss.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of aPC
    • Identify the present treatment options currently available for management of aPC
    • Evaluate the safety and effectiveness of certain treatment options in specific patient populations and apply this knowledge to patient cases using evidence-based medicine
    • Describe complications associated with prostate cancer and its treatment (bone, cardiovascular, and endocrinologic risk factors) and develop risk mitigation and optimization strategies

    Target Audience:

    The following HCPs: oncologists and urologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in oncology; and any other HCPs with an interest in or who may clinically encounter patients with aPC.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 5/19
    • Expiration of CME credit: 5/21
  • FREE

    CME: Gaucher disease: Updates from recent research findings

    Gaucher disease (GD) is characterized by a deficiency of the lysosomal enzyme glucocerebrosidase, resulting in the accumulation of sphingolipids throughout the body but most manifesting prominently in the bones. GD is subcategorized based on clinical features: type 1 GD is the non-neuronopathic form and affects mainly the inner organs, while types 2 and 3 are the acute and sub-acute neuropathic forms, whose pathology manifests predominantly within central nervous system. GD impacts about 1 in 75,000 births, making it one of the most common lysosomal storage diseases. One of the first of GD’s complications is the chronic anemia and a persistent bleeding risk. Another is the hepatosplenomegaly, which may be a part of the initial clinical presentation, as may the anatomical abnormalities of bone deformities and stunted growth.

    By the end of the session the participant will be able to:

    • Describe the pathogenesis, clinical presentations, complications, and epidemiology of Gaucher disease including updated recently presented material
    • Describe principles and problems regarding screening for and diagnosing Gaucher disease that can applied to patient cases
    • Describe emerging therapies for Gaucher disease based on research recently presented
    • Design and implement appropriate therapeutic plans for treatment of Gaucher disease based on research recently presented

    Target Audience:

    The following healthcare professionals: pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Gaucher disease.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 4/28/19
    • Expiration of CME credit: 4/28/21
  • FREE

    Interstitial Lung Disease with Progressive Lung Disease Phenotype (ILD-PF): Therapeutic Updates, Best Practices, and Emerging Therapies

    Interstitial lung disease (ILD) is a collective term used to categorize more than 200 different types of diseases that affect the alveolar structures, the pulmonary interstitium, and small airways.

    After completing Interstitial Lung Disease with Progressive Lung Disease Phenotype (ILD-PF): Therapeutic Updates, Best Practices, and Emerging Therapies you will be able to:

    • Describe the pathophysiology of and risk factors for ILD-PF such that it might inform treatment mechanisms and strategies
    • Identify signs and symptoms of ILD-PF (e.g., rheumatoid arthritis, chronic hypersensitivity pneumonitis, unclassified ILD)
    • Describe the prevalence, morbidity, and mortality, burden of illness associated with ILD-PF and, conversely, the benefits associated with early identification and treatment
    • Describe current treatment standards and monitoring parameters (HRCT, PFTs) of ILD-PF, including developments in clinical research and treatment guidelines, and apply them to patient cases
    • Discuss ways to improve clinician communication with their patients, including disease education

     

    Target Audience: pulmonologists, rheumatologists, primary care physicians, pathologists, dermatologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in pulmonology; and any other HCPs who have an interest in or otherwise clinically encounter patients with ILD-Pf.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: January 27, 2019
    • Expiration of CME credit: January 27, 2021
  • FREE

    Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies

    Transthyretin amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils.

    After completing Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies physicians will better be able to:

    • Describe the pathophysiology of ATTR such that it might inform treatment mechanisms
    • Describe available therapies used for treatment of ATTR and explain current literature supporting use of those therapies
    • Design and implement an appropriate therapeutic plan for treatment of ATTR
    • Describe future therapies currently being investigated for the treatment of ATTR

    Target Audience: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, nurses, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 28, 2019
    • Expiration of CME credit: March 28, 2021
  • FREE

    Short Bowel Syndrome – updates from DDW 2018

    Short bowel syndrome (SBS) is a condition in which a patient exhibits malabsorption-induced diarrhea, dehydration, electrolyte imbalances, and malnutrition due to decreased nutrient absorption that results from extensive surgical resection of the intestine or congenital defects. It is a form of intestinal failure (IF), which is defined as a need for supplementary parenteral or enteral nutrition when intestinal function is insufficient to meet the body’s nutritional requirements.

    After reviewing Short Bowel Syndrome – updates from DDW 2018 physicians will better be able to:

    • Describe current trends in the epidemiology of SBS
    • List causes of SBS in pediatrics and adults
    • Review the clinical manifestations and complications of SBS
    • Summarize updates in medical management in SBS and apply them to patient cases
    • Discuss surgical strategies in the management of SBS and apply them to patient cases

    Target Audience: gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with Short Bowel Syndrom.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: October 07, 2018
    • Expiration of CME credit: October 07, 2020
  • FREE

    Binge Eating Disorder (BED): Therapeutic Updates, Best Practices, and Barriers to Care

    This free online CME self-learning program provides deep insights into Binge Eating Disorder (BED) and features commentary from experts on the topic.

    Topics covered in this program include

    • BED epidemiology
    • BED comorbidities
    • BED treatment
    • BED diagnosis

    After completing this course, you will better be able to:

    • Describe the importance of accurate diagnosis and treatment of BED.
    • Determine likelihood of BED using established methods in a patient case.
    • Describe available therapies used for treatment of BED and summarize* recent literature supporting use of those therapies
    • Design a therapeutic regimen, including pharmacotherapy, for the treatment of BED
    • Describe barriers preventing the optimal treatment of BED

    Target Audience: Psychiatrists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter patients with BED.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: September 04, 2018
    • Expiration of CME credit: September 04, 2021
  • FREE

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies is a free CME course that looks into the diangosis and treatment of Systemic Sclerosis Interstitial Lung Disease (SSc-ILD).

    Topics covered in this course include

    • SSc-ILD Epidemiology and risk factors
    • SSc-ILD Pathophysiology
    • SSc-ILD Diagnosis
    • Treatment of SSc-ILD
    • SSc-ILD

    After completing this course, you will better be able to:

    • Describe the etiology of SSc-ILD and its impact on patient clinical presentation and available pharmacotherapeutic treatments
    • Describe the prevalence, clinical features, and presentation of SSc-ILD
    • Evaluate treatments plans for SSc-ILD patients and suggest appropriate therapies, where applicable, based on individual presentations
    • Describe present and emerging drug therapies for management of SSc-ILD and apply them to patient cases taking into account the patient’s history
    • Describe clinical and logistical challenges associated with treating and educating patients with SSc-ILD

    Target audience: The following HCPs: pulmonologists, rheumatologists, primary care physicians, pathologists, dermatologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in pulmonology; and any other HCPs who have an interest in or otherwise clinically encounter patients with Ssc-ILD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: August 20, 2018
    • Expiration of CME credit: July 20, 2020
  • FREE

    Multiple Myeloma (MM): Highlights from the American Society for Clinical Oncology (ASCO) 2018

    This free online CME program covers key learnings around Multiple Myeloma from the American Society for Clinical Oncology 2018 Conference.

    After completing this course, physicians will better be able to:

    • Summarize the most impactful findings presented at ASCO 2018 relating to Multiple myeloma and apply them to patient cases, taking into account any relevant barriers to care.
    • Additional objectives to be dictated by clinical content

    Target Audience: The following healthcare professionals: hematologists and oncologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with MM.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 19, 2018
    • Expiration of CME credit: July 19, 2020
  • FREE

    Updates in Alzheimer Disease (AD) and Its Complications: Pharmacotherapy and Barriers to Optimal Care

    This free online CME course provides key insights around Alzheimer’s Disease (AD) and will lead to better understanding and treatment of the condition.

    Topics covered in this course include:

    • AD Treatment
    • AD Patient Cases
    • AD Clinical Pearls
    • ADPathophysiological process
    • Epidemiology

    After completing this course, you will better be able to:

    • Describe validated diagnostic and screening method(s) for AD and apply them to a patient case
    • Discuss the neuropathophysiology of AD and how it relates to presently available AD treatments’ mechanisms
    • List present and emerging pharmacotherapeutic therapies for the treatment of AD and its complications and apply them to patient cases, taking into account comorbid disease states and drug therapies
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with AD

    Target audience: Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 07, 2018
    • Expiration of CME credit: July 07, 2020
  • FREE

    Hypoparathyroidism: therapeutic updates and optimizing treatment

    This free online CME course provides insights into Hypoparathyroidism and how to most effectively treat the condition.

    Topics covered in the course include:

    • Treatment of hypoparathyroidism
    • Barriers to optimal care
    • Hypoparathyroidism patient cases

    After completing thise course, you will better be able to:

    • Describe the pathophysiology and underlying etiologies of hypoparathyroidism and apply these to patient cases.
    • Describe the clinical manifestations of hypoparathyroidism and discuss how they may have relevance to treatment targets.
    • Identify available therapeutic options for hypoparathyroidism and incorporate these in the development of treatment plans in patient cases.
    • Define patient-specific goals related to the management of hypoparathyroidism.

    Target Audience: Endocrinologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with hypoparathyroidism.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: June 06, 2018
    • Expiration of CME credit: June 06, 2020